Eccogene is a research driven biopharmaceutical company focusing on developing immune and metabolic modulators for the treatment of metabolic disease, inflammatory disease, cancer and autoimmune disorders. Eccogene is founded by a group of seasoned drug hunters with track record of inventing FDA approved drug. Our fully integrated R&D center locates in Shanghai Zhangjiang Hi-tech park. By leveraging internal and external capabilities, Eccogene aims to discover and develop innovative medicines to address the unmet medical needs globally.